Break-through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Break-through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia A

Published:2017-12-01 Issue:1 Volume:24 Page:120-125
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Cheng X.¹^ORCID,Li P.²^ORCID,Chen Z.²^ORCID,Zhang N.²,Zhen Y.²,Zhao L.¹,Wang X.¹,Wu R.²

Affiliation:

1. Department of Pharmacy; Beijing Children's Hospital; Capital Medical University; Beijing China

2. Hematology Oncology Center; Beijing Children's Hospital; Capital Medical University; Beijing China

Funder

Capital Health Research and Development of special

Beijing Municipal Administration of Hospitals Clinical medicine Development

BAXTER Investigator Initiated Research Agreement

Bayer Investigator Initiated Research Agreement

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13373/fullpdf

Reference33 articles.

1. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group;Aledort;J Intern Med,1994

2. Health-related quality of life as outcome parameter in haemophilia treatment;Fischer;Haemophilia,2003

3. Quality-of-life differences between prophylactic and on-demand factor replacementtherapy in European haemophilia patients;Royal;Haemophilia,2002

4. Factor VIII half-life and clinical phenotype of severehemophilia A;Karin van;Disord Hemost,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Approaches in Preclinical Studies on Drug Discovery and Development;Frontiers in Chemistry;2020-09-11

2. Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes;Haemophilia;2019-05-21

3. Model‐based evaluation of low‐dose factor VIII prophylaxis in haemophilia A;Haemophilia;2019-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3